THURSDAY, Oct. 5, 2023 (HealthDay News) — A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found. The trial, of nearly 700 people with treatment-resistant depression, found that esketamine nasal spray was moreContinue Reading

WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Breast cancer patients who undergo a mastectomy can probably benefit from a shorter course of more intense radiation therapy, a new study indicates. Hypofractionated radiation therapy — which provides a higher dose each session over three weeks — provides the same protection againstContinue Reading

TUESDAY, Oct. 3, 2023 (HealthDay News) — A popular type of off-road vehicle known as a “side-by-side” has been linked to high rates of severe hand injuries, according to a new study. Side-by-sides are utility terrain vehicles (UTVs) designed to carry more than one passenger and heavy loads. All-terrain vehiclesContinue Reading

THURSDAY, Sept. 28, 2023 (HealthDay News) – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS. Although the FDA isn’t bound by the votes of its advisory panels, agency scientists have already penned a scathing reviewContinue Reading